A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

949

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

July 7, 2028

Study Completion Date

July 7, 2028

Conditions
Cervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal CancerNon-Small-Cell Lung CancerSquamous Cell Carcinoma of Head and NeckCarcinoma, Renal CellUrothelial CarcinomaPancreatic AdenocarcinomaMelanomaOvarian NeoplasmsTriple Negative Breast Neoplasms
Interventions
DRUG

BMS-986340

Specified dose on specified days

DRUG

BMS-936558-01

Specified dose on specified days

DRUG

Docetaxel

Specified dose on specified days

Trial Locations (50)

2148

RECRUITING

Blacktown Hospital, Blacktown

2170

RECRUITING

Liverpool Hospital, Liverpool

3065

RECRUITING

St Vincent's Hospital, Melbourne

3144

RECRUITING

Cabrini Hospital - Malvern, Malvern

4102

RECRUITING

Princess Alexandra Hospital, Brisbane

6009

RECRUITING

One Clinical Research, Nedlands

10032

ACTIVE_NOT_RECRUITING

Local Institution - 0006, New York

10060

RECRUITING

Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo

10065

COMPLETED

Local Institution - 0002, New York

20089

RECRUITING

Humanitas, Rozzano

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1, Milan

28040

RECRUITING

Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28050

RECRUITING

Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid-CIOCC, Madrid

29010

RECRUITING

Hospital Universitario Virgen de la Victoria, Málaga

31008

RECRUITING

Clinica Universidad de Navarra-oNCOLOGY, Pamplona

37067

NOT_YET_RECRUITING

Local Institution - 0063, Nashville

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

45147

RECRUITING

Universitaetsklinikum Essen, Essen

52242

RECRUITING

University of Iowa, Iowa City

53100

RECRUITING

ospedale le scotte-U.O.C. Immunoterapia Oncologica, Siena

60590

RECRUITING

Universitatsklinikum Frankfurt, Frankfurt

77030

RECRUITING

Houston Methodist Hospital, Houston

80131

RECRUITING

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli

89081

RECRUITING

Universitaetsklinikum Ulm, Ulm

90033

RECRUITING

USC/Norris Comprehensive Cancer Center, Los Angeles

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

93611

RECRUITING

Community Cancer Institute, Clovis

97078

RECRUITING

Universitaetsklinikum Wuerzburg, Würzburg

97213

RECRUITING

Providence Cancer Center Oncology and Hematology Care- Eastside, Portland

100142

NOT_YET_RECRUITING

Local Institution - 0067, Beijing

250117

NOT_YET_RECRUITING

Local Institution - 0066, Jinan

310022

NOT_YET_RECRUITING

Local Institution - 0065, Hangzhou

3109601

RECRUITING

Rambam Health Care Campus, Haifa

4941492

RECRUITING

Rabin Medical Center, Petah Tikva

5265601

WITHDRAWN

Local Institution - 0035, Ramat Gan

RECRUITING

Sheba Medical Center, Ramat Gan

6423906

RECRUITING

Sourasky Medical Center, Tel Aviv

07601

RECRUITING

John Theurer Cancer Center, Hackensack

T6X 1E8

RECRUITING

Cross Cancer Institute, Edmonton

V5Z 4E6

RECRUITING

BC Cancer Vancouver, Vancouver

L8V5C2

RECRUITING

Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton

M5G 2M9

COMPLETED

Local Institution - 0009, Toronto

H2X 0A9

RECRUITING

Centre Hospitalier de luniversite de Montreal, Montreal

K1H 8L6

RECRUITING

The Ottawa Hospital Cancer Centre, Ottawa

01307

RECRUITING

Universitaetsklinikum Carl Gustav Carus Dresden-University Cancer Center Early Clinical Trial Unit, Dresden

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa

08916

RECRUITING

Institut Catalan d Oncologia (ICO) - Badalona, Badalona

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04895709 - A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter